The Spectrum Brief
Autism research, in plain language
← Back to the feed

Diagnosis & ScreeningResearch

Autism Identification Rises to 1 in 31 U.S. Children, CDC Reports, With Reduced Disparities

New data shows improved screening and access are narrowing racial and gender gaps in autism diagnoses—not an 'epidemic.'

By The Spectrum Brief newsroom · 2 hours ago·Based on peer-reviewed research
Share

Improved Identification, Not an Epidemic

The prevalence of autism among 8-year-olds in the U.S. has risen to 1 in 31 (3.2%) in 2022, up from 1 in 36 (2.8%) in 2020, according to the CDC's latest surveillance data. The findings, published in April 2025, come from the Autism and Developmental Disabilities Monitoring (ADDM) Network, which tracks diagnoses across 16 U.S. sites. Experts emphasize that the increase reflects improved screening, diagnostic access, and awareness—particularly in historically underserved groups—rather than a true rise in autism cases.

Narrowing Disparities

A notable shift in the data is the reduced gap in identification rates among racial and ethnic groups. Black, Hispanic, and Asian/Pacific Islander children saw significant increases in autism diagnoses, closing longstanding disparities. For example, Black children were 1.2 times more likely to be identified as autistic in 2022 compared to 2020, while Hispanic children saw a 1.3-fold increase. These trends suggest progress in addressing systemic barriers to diagnosis, such as limited access to healthcare providers or cultural biases in screening tools, as Johns Hopkins researchers noted.

has risen to 1 in 31 (3.2%) in 2022, up from 1 in 36 (2.8%) in 2020, according to the CDC's latest surveillance data.

The male-to-female diagnosis ratio also decreased slightly, from 4.2:1 in 2020 to 3.8:1 in 2022. This shift may indicate growing recognition of autism in girls and women, who have historically been underdiagnosed due to differences in how traits present.

What’s Behind the Numbers?

The CDC attributes the rising prevalence to better early screening and expanded access to services, not environmental factors. As MedPage Today reported, the ADDM Network’s methodology relies on reviewing health and education records, meaning the data captures identified cases rather than total prevalence. The CDC stresses that autism is a lifelong neurodevelopmental variation, not a disease to be cured.

Despite the scientific consensus, some political figures have misrepresented the data to promote debunked causation theories, such as links to vaccines or painkillers. Public health experts caution against this framing, noting that the term 'epidemic'—used in some press releases—is not supported by evidence. As CNN highlighted, the rise is a sign of progress in identifying autistic children earlier and more equitably.

#autismprevalence#CDC#healthdisparities#diagnosis#neurodiversity

Common questions

Share

Behind the brief

Adversarial editorial review

Approved87/100 consensus· 2 rounds

Open thread

Discussion

0 comments · The editorial board joins in. Be kind and cite sources where you can.

Loading comments…